Global Antacid Market Insights and Forecast to 2031

Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid.
The global average price of Antacid is in the decreasing trend, from 11.43 USD/Unit in 2013 to 10.73 USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.

Market Analysis and Insights: Global Antacid Market
The global Antacid market is valued at US$ 6225.7 million in 2019. The market size will reach US$ 6587 million by the end of 2026, growing at a CAGR of 0.8% during 2021-2026.

Global Antacid Scope and Market Size
Antacid market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antacid market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Proton Pump Inhibitor
H2 Antagonist
Acid Neutralizers

Segment by Application
OTC Drug
Rx Drug

By Company
AstraZeneca
Takeda Pharmaceutical
Pfizer
Reckitt Benckiser
Bayer
Procter＆Gamble
GlaxoSmithKline
Johnson＆Johnson
CONBA
Xiuzheng Pharma
Sanofi
Bausch Health
CR SANJIU
Reddy's Laboratories

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia